Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

NCT01596621

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Teva Investigational Site 001 Beijing, China
  • Teva Investigational Site 026 Beijing, China
  • Teva Investigational Site 022 Beijing, China
  • Teva Investigational Site 004 Beijing, China
View all 27 locations
View Trial Details
Completed

ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

NCT04121507

Conditions
Aggressive Non-hodgkin Lymphoma (aNHL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • HELIOS Klinik Berlin-Buch, Klinik für Hämatologie und Stammzelltransplantation Berlin, Brandenburg, Germany
  • Klinikum Augsburg, Medizinische Klinik II Augsburg, Germany
  • Medizinisches Universitätsklinikum Bochum, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 13 locations
View Trial Details
Completed

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

NCT00287105

Conditions
Acute Lymphoblastic Leukemia, Chromosome Aberrations, Hematologic Diseases, +14 more
Locations
  • Service d'hématologie pédiatrique CHRU Amiens, France
  • Service hématologie pédiatrique Hôpital Saint-Jacques Besançon, France
  • Service d'hémato-oncologie - Hôpital des Enfants Pellegrin Bordeaux, France
  • Hôpital Morvan Brest, France
View all 22 locations
View Trial Details
Completed

Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19

NCT04391946

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease, Disease Attributes, +14 more
Locations
  • Chu Angers Angers, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
  • CHU Estaing - Hématologie Clinique Adulte Clermont-Ferrand, France
View all 22 locations
View Trial Details
Completed

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

NCT00602459

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • PCR Oncology Arroyo Grande, California, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
View all 364 locations
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

NCT03236857

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Disease Attributes, +28 more
Locations
  • Univ California, San Francisco /ID# 163460 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 161551 Aurora, Colorado, United States
  • Children's Healthcare of Atlan /ID# 161552 Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute /ID# 163440 Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Completed

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

NCT03003520

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +11 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 20 locations
View Trial Details

Related conditions